Professor Michael Kershaw: Ledger

Stories naming Professor Michael Kershaw. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

Role	Organisation	Sources
Head of the Immune Innovation Laboratory	Peter MacCallum Cancer Centre	Brandon Capital portfolio (Mon 28 Jun 2021), Brandon BioCatalyst portfolio (Mon 28 Jun 2021), Brandon BioCatalyst portfolio (Mon 28 Jun 2021), Brandon Capital portfolio (Mon 28 Jun 2021)

Unnamed stage $10m

Brandon Capital, Uniseed back cancer biotech start-up in $10m funding

Melbourne cancer immunotherapy startup Currus Biologics, spun out of Peter MacCallum, raised $10 million led by the Brandon Capital-managed Medical Research Commercialisation Fund with Uniseed, to advance its BEAT technology toward human trials.

Brandon Capital portfolio Mon 28 Jun 2021 Currus Biologics Brandon Capital Chimeric Therapeutics Imugene Medical Research Commercialisation Fund (MRCF)Peter MacCallum Cancer Centre Uniseed Dr Clare Slaney Leslie Chong Professor Michael Kershaw Sam Cobb

Also Brandon BioCatalyst portfolio·Brandon BioCatalyst portfolio·Brandon Capital portfolio·Brandon BioCatalyst portfolio·SmartCompany·Startup Daily·SmartCompany·Startup Daily

Professor Michael Kershaw

Roles

Coverage

Brandon Capital, Uniseed back cancer biotech start-up in $10m funding